Remove Government Remove Patients Remove Pharma Remove Pharmaceutical manufacturing
article thumbnail

As pharma abandons the antibiotic market patients are at risk

World of DTC Marketing

A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market. Pew Internet reminds us all that, above all, the pharma industry is a business. The pharma industry is warning of the consequences of inaction. “If

Pharma 174
article thumbnail

How one pharma “family business” places patients first

pharmaphorum

When people think about pharma, they often think about “big” pharma: large, faceless corporations. And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. Caring for a global community.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Research Reveals Three Ways Pharma Can Better Prioritize Payer Audiences

PM360

The pandemic had a huge impact on the way population health decision-makers (PHDMs) navigate our industry, and now that it’s clear many of these shifts are here to stay, pharmaceutical manufacturers need to adjust accordingly. We get so little comparative effectiveness data from pharma.”

Pharma 92
article thumbnail

How can the pharma industry address the gap in talent recruitment and development?

pharmaphorum

Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks. For instance, in pharmaceutical manufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches.

article thumbnail

How Supply Chain Planning Can Help Pharma Meet All-Time High Drug Supply Demands

PM360

Patients struggle to get the necessary treatments, in some cases resulting in increased hospitalization and death. The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. Some suggest that the government should incentivize U.S. Over 300 drugs in the U.S.

article thumbnail

A Powerful Point-of-Sale Partnership that Delivers on the Promise of Affordable Insulin

PM360

In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. The price is available to cash-paying patients with a valid prescription. for only $35. Currently, an estimated 37.3

Retail 52
article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.